Articles by Jason Mast
The Food and Drug Administration has again paused trials for Regenxbios gene therapy for a rare childhood brain disorder, after small masses were found on the spines of five patients, the company saiοΏ½...
The Food and Drug Administration said Monday that Capricor Therapeutics stem cell treatment for Duchenne muscular dystrophy did not meet the objectives of a Phase 3 trial contrary to the companys claοΏ½...
When 13-month-old Adams stem cell transplant failed, doctors had two options: a second transplant, which they warned carried a 10% to 15% risk of death, or a new and untested gene therapy.
His parenοΏ½...
The Food and Drug Administration on Friday rejected again an experimental treatment for advanced skin cancer developed by Replimune Group.Β
Replimunes treatment, an engineered virus designed to rev ...
Gene therapy researchers were converging on a holy grail. A few years ago, researchers at labs and companies reported they had engineered viruses that could ferry corrective genes deep into the brainοΏ½...
For the ailing gene editing industry, hope came earlier this month in the tiny, smiling, fuzzy-headed form of KJ Muldoon.
At just 6 months old, KJ received a gene editing treatment custom-built to cοΏ½...
